Vagally Mediated Heart Rate Variability: A Risk Factor for Hypertension

Hypertension is among the leading causes of mortality and an important contributor toward disability-adjusted life years worldwide. Several factors contribute toward individuals’ risk to develop hypertension. Stress is considered an important pathogenic component affecting blood pressure regulation....

Full description

Bibliographic Details
Main Author: Christou-Champi, S. (Author)
Format: Article
Language:English
Published: International Society for Neurofeedback and Research 2021
Subjects:
Online Access:View Fulltext in Publisher
LEADER 02917nam a2200385Ia 4500
001 10.15540-nr.8.3.173
008 220427s2021 CNT 000 0 und d
020 |a 23730587 (ISSN) 
245 1 0 |a Vagally Mediated Heart Rate Variability: A Risk Factor for Hypertension 
260 0 |b International Society for Neurofeedback and Research  |c 2021 
856 |z View Fulltext in Publisher  |u https://doi.org/10.15540/nr.8.3.173 
520 3 |a Hypertension is among the leading causes of mortality and an important contributor toward disability-adjusted life years worldwide. Several factors contribute toward individuals’ risk to develop hypertension. Stress is considered an important pathogenic component affecting blood pressure regulation. However, systematic reviews examining the effect of psychosocial stressors and anxiety on hypertension produced spurious results. The observed heterogeneity in the operationalization of stress and subsequent reactivity hindered the characterization of the evidence for the association between exposure, physiological reactivity, and risk for hypertension. This is of paramount importance as physiological reactivity constitutes a biological interface mechanism through which stressors affect blood pressure regulation. The neural substrates of vagally mediated heart rate variability (VM-HRV) indicate that it is able to assimilate such an interfacing mechanism. Large-scale epidemiological studies provided substantial evidence linking decreases in VM-HRV with the development and progression of hypertension, indicating that individuals’ reactivity to stressors, as measured via VM-HRV, increases individuals’ risk for the development and progression of hypertension. As such, VM-HRV can reinforce current screening initiatives and support treatment-related prognosis. Self-regulation techniques, like heart rate variability biofeedback (HRVB), and neuromodulation techniques, like cranial electrotherapy stimulation (CES), are able to enhance VM-HRV and the associated parasympathetic modulation of cardiovascular outcomes, and thus address autonomic imbalances associated with hypertension. Copyright: © 2021. Christou-Champi. 
650 0 4 |a anxiety 
650 0 4 |a Article 
650 0 4 |a biofeedback 
650 0 4 |a Biofeedback 
650 0 4 |a blood pressure regulation 
650 0 4 |a cardiovascular autoregulation 
650 0 4 |a Central autonomic network 
650 0 4 |a Cranial electrotherapy stimulation 
650 0 4 |a electrotherapy 
650 0 4 |a heart rate variability 
650 0 4 |a Heart rate variability 
650 0 4 |a human 
650 0 4 |a hypertension 
650 0 4 |a Hypertension 
650 0 4 |a neuromodulation 
650 0 4 |a physiological stress 
650 0 4 |a prognosis 
650 0 4 |a risk factor 
650 0 4 |a Stress 
650 0 4 |a transcranial electrical stimulation 
650 0 4 |a vagus nerve 
700 1 |a Christou-Champi, S.  |e author 
773 |t NeuroRegulation